Previous close | 7.75 |
Open | 8.35 |
Bid | 7.85 |
Ask | 8.10 |
Strike | 140.00 |
Expiry date | 2022-11-18 |
Day's range | 8.30 - 8.50 |
Contract range | N/A |
Volume | |
Open interest | 1.04k |
JPMorgan Chase, AbbVie, Abbott Laboratories, Intuit and Caterpillar are included in this Analyst Blog.
Today's Research Daily features new research reports on 12 major stocks, including JPMorgan Chase & Co. (JPM), AbbVie Inc. (ABBV) and Abbott Laboratories (ABT).
I-Mab's (IMAB) partner AbbVie decides to stop early-stage development of an anti-CD47 antibody therapy targeting multiple cancer indications. IMAB intends to support the candidate's development.